Ivan Hyep, Chief Financial Officer at Bicara Therapeutics Inc. (BCAX), sold 33,036 shares at $18.22 ($602K) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Open-market sale of $602k BCAX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.22 | 13,555 | $247K | 41.0% |
| 2 | $18.22 | 13,555 | $247K | 41.0% |
| 3 | $18.25 | 2,963 | $54K | 9.0% |
| 4 | $18.25 | 2,963 | $54K | 9.0% |
| Total | $18.22 avg | 33,036 | $602K | 100% |
| Filing → |
| BCAX | SELL | 2026-05-26 | $188K | — | Filing → |
| BCAX | SELL | 2026-04-22 | $212K | — | Filing → |
| BCAX | SELL | 2026-03-24 | $341K | — | Filing → |